Moffat Karen A, Ledford-Kraemer Marlies R, Nichols William L, Hayward Catherine P M
Hamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada.
Thromb Haemost. 2005 Mar;93(3):549-53. doi: 10.1160/TH04-10-0670.
Disorders of platelet function are important causes of abnormal bleeding that require laboratory tests for diagnosis. Currently there are limited guidelines on how to perform clinical testing for these disorders. The goal of our study was to obtain information on how disorders of platelet function are currently evaluated in clinical laboratories. Two patterns-of-practice surveys were distributed to laboratories of the North American Specialized Coagulation Laboratory Association (NASCOLA). The information collected was analyzed to determine practices and common problems. Forty-seven NASCOLA laboratories participated and 54% completed both surveys. The majority of the laboratories that responded performed more than 50 aggregation tests per year, mainly using platelet rich plasma based methodologies. A minority performed testing for platelet secretion and dense granule abnormalities. While platelet aggregation results were reviewed in various ways, laboratories most commonly issued a combined report containing quantitative values (% aggregation and/or slope) and a qualitative interpretation. Although laboratories used similar agonists for aggregation testing, the final agonist concentrations varied widely. Several approaches were also used to obtain reference intervals. Comments offered by the participants indicated that performing, and interpreting platelet function tests were challenging for many clinical laboratories. Although common practices have evolved, there is considerable variability in the diagnostic test procedures used by clinical laboratories to evaluate disorders of platelet function. These patterns-of-practice surveys illustrate a need for guidelines and recommendations for clinical laboratories performing tests of platelet function.
血小板功能障碍是导致异常出血的重要原因,需要通过实验室检查来进行诊断。目前,关于如何对这些障碍进行临床检测的指南有限。我们研究的目的是获取有关临床实验室目前如何评估血小板功能障碍的信息。两项实践模式调查被分发给北美专业凝血实验室协会(NASCOLA)的各实验室。对收集到的信息进行分析,以确定实践情况和常见问题。47个NASCOLA实验室参与了调查,54%的实验室完成了两项调查。大多数做出回应的实验室每年进行超过50次聚集试验,主要采用基于富血小板血浆的方法。少数实验室对血小板分泌和致密颗粒异常进行检测。虽然血小板聚集结果以各种方式进行审查,但实验室最常发布包含定量值(聚集百分比和/或斜率)和定性解释的综合报告。尽管实验室在聚集试验中使用了相似的激动剂,但最终激动剂浓度差异很大。还采用了几种方法来获得参考区间。参与者提供的意见表明,对许多临床实验室来说,进行和解释血小板功能测试具有挑战性。尽管常见做法有所发展,但临床实验室用于评估血小板功能障碍的诊断测试程序仍存在相当大的差异。这些实践模式调查表明,需要为进行血小板功能测试的临床实验室制定指南和建议。